Beam Therapeutics Inc.
Institutional investors holding BEAM
| Investor | Weight | Quarter |
|---|---|---|
| Bill Ackman | 11.60% | 2014Q1 |
| Meridian / ArrowMark | 0.01% | 2020Q1 |
| Kenneth Fisher | 0.00% | 2011Q4 |
| Bill Nygren | 0.00% | 2012Q2 |
| Polen Capital Management | 0.00% | 2025Q3 |
Congressional data coming soon
14
Total trades
$2.0M
Volume
6
Buys
6
Sells
Last trade: Apr 1, 2026
| Date | Insider | Type | Value |
|---|---|---|---|
| Apr 1, 2026 | John M. Evans | Sell | $290K |
| Apr 1, 2026 | John M. Evans | Sell | $146K |
Congressional trade data is being sourced and will appear here shortly.
| Apr 1, 2026 |
| John M. Evans |
| Sell |
| $80K |
| Apr 1, 2026 | John M. Evans | Sell | $165K |
| Apr 1, 2026 | John M. Evans | Sell | $739K |
| Mar 31, 2026 | John M. Evans | Buy | – |
| Mar 31, 2026 | John M. Evans | Buy | – |
| Mar 31, 2026 | John M. Evans | Buy | – |
| Mar 31, 2026 | John M. Evans | Buy | – |
| Mar 31, 2026 | John M. Evans | Buy | – |
| Mar 30, 2026 | John M. Evans | Sell | $559K |
| Mar 30, 2026 | John M. Evans | Option | $17K |
| Mar 30, 2026 | John M. Evans | Buy | – |